COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,442 Articles (22,835 medRxiv, 8,607 bioRxiv)

Most recent first Previous |  Page 13: Articles 121-130  | Next

Occupational and Environmental Challenges and Effects of COVID-19 Testing Implementation Experienced by HIV Viral Load Laboratory Staff within a Public Health Sector Laboratory in South Africa
Sarang, S., Matingo-Mutava, E., Cassim, N.
10.64898/2026.02.16.26346134 — Posted: 2026-02-22
Low Dose Naltrexone Prescribing Practices for Children and Adolescents with Long COVID
Villatoro, C., Yonts, A. B., Barter, T., Mohandas, S., Malone, L. A.
10.64898/2026.02.20.26346719 — Posted: 2026-02-22
Assessing the impact of the COVID-19 pandemic on routine childhood vaccination uptake in the Netherlands
Pijpers, J., Haverkate, M., van Gaalen, R., Hahne, S., de Melker, H., van den Hof, S.
10.64898/2026.02.19.26346601 — Posted: 2026-02-20
TMPRSS2 reduces antibody recognition of SARS-CoV-2 spike
Cottignies-Calamarte, A., De Cruz, A., Planchais, C., Porrot, F., Krzypow, M., Jungbauer-Groznica, M., Thuillier, E., Wileveau, A., Staropoli, I., Guivel-Benhassine, F., Rosenbaum, P., Fernandez, I., Rey, F. A., Buchrieser, J., Trouillet-Assant, S., Mouquet, H., Schwartz, O., Bruel, T.
10.64898/2026.02.17.706397 — Posted: 2026-02-20
Potential public health and economic impact of the next-generation COVID-19 vaccine mRNA-1283 in the Netherlands
van der Pol, S., Beck, E., Westra, T., Postma, M., Boersma, C.
10.64898/2026.02.18.26346561 — Posted: 2026-02-19
Early Fc-effector antibody signatures impact COVID-19 disease trajectory
Escalera, A., Gonzalez-Reiche, A. S., Aslam, S., Bernal, E., Alter, G., Rojo-Fernandez, A., Rombauts, A., Abelenda-Alonso, G., Amper, M. A., Nair, V. D., van Bakel, H., Carratala, J., Garcia-Sastre, A., Aydillo, T.
10.64898/2026.02.18.26346542 — Posted: 2026-02-19
The buried S2 apex of SARS-CoV-2 spike elicits an immunodominant germline-restricted public antibody response
Park, S., Mischka, J., Okba, N., Abbad, A., Yuan, M., Srivastava, K., Gleason, C., Mulder, L. C. F., Copps, J., Saam, K., Bangaru, S., Krammer, F., Wilson, I. A., Simon, V., Ward, A. B.
10.64898/2026.02.18.706653 — Posted: 2026-02-19
COVID-19 Symptom burden, chronic disease, mental health, and executive function: Multi-Country evidence from four African countries"
Malete, L., Ezeamama, A., Ricketts, C., Joachim, D., Naghibolhosseini, M., Zayernouri, M., Ocansey, R., Muomah, R. C., Tladi, D. M., Ndabi, J. S.
10.64898/2026.02.16.26346431 — Posted: 2026-02-18
Revised estimates of the types and durations of long Covid symptoms based on claims records from 245 Million US patients
Nilforoshan, H., Reisler, J., Jahanparast, E., Moor, M., Goodman, S., Wager, S., Leskovec, J.
10.64898/2026.02.17.26346448 — Posted: 2026-02-18
Adherence to Public Health Recommendations, Restrictions, and Requirements among Priority Populations at Risk for COVID-19 Mortality and Infection in Australia
Narayanasamy, S., Altermatt, A., Wilkinson, A. L., Heath, K., Gibney, K., Hellard, M., Pedrana, A.
10.64898/2026.02.15.26346356 — Posted: 2026-02-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).